"Drug Xeloda Prolongs Survival For Some Breast Cancer Patients" - Amy Norton
A drug called Xeloda can extend the lives of women whose breast cancer is not wiped out by standard treatment, a new clinical trial finds. Stephen Malamud, MD, associate professor of medical oncology at the Icahn School of Medicine at Mount Sinai said "Xeloda is a pill, so it's easy to take and is much less toxic than standard chemotherapy, most importantly, it extended overall survival in this study."
- Stephen Malamud, MD, Associate Professor, Medicine, Hematology, Medical Oncology, Icahn School of Medicine at Mount Sinai
Learn more
Additional Coverage:
HealthDay
WREX
Study Reveals New Insights Into Immune System Role in Lung Cancer Risk
Feb 22, 2024 View All Press Releases
Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer
Jan 26, 2024 View All Press ReleasesMount Sinai’s Staten Island Cancer Center Moves to New Site
Nov 09, 2023 View All Press Releases
Scientists Create Most Powerful, Accurate Tool Yet to Research Deadliest Blood Cancer
Apr 18, 2023 View All Press Releases